Alto Neuroscience (ANRO) Stock Chart & Stock Price History → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free ANRO Stock Alerts $14.60 +0.72 (+5.19%) (As of 05/9/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Alto Neuroscience Stock Price Performance5 Day Performance+2.67%1 Month Performance-0.88%3 Month Performance-11.78% Receive ANRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alto Neuroscience and its competitors with MarketBeat's FREE daily newsletter Email Address Ad True Market InsidersExposed: 10 CENT Crypto to Explode May 20th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 ANRO Stock Chart for Thursday, May, 9, 2024 ANRO Chart by TradingView Alto Neuroscience Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/09/2024$13.88$14.60+5.19%$14.66$13.7643,621 shs$392.51 million05/08/2024$15.01$13.88-7.53%$14.90$13.6751,592 shs$373.09 million05/07/2024$14.30$15.01+4.97%$15.07$14.3282,216 shs$403.47 million05/06/2024$14.22$14.30+0.56%$14.77$13.80141,055 shs$384.38 million05/03/2024$14.40$14.22-1.25%$14.64$13.87114,893 shs$382.23 million05/02/2024$16.10$14.40-10.56%$16.13$14.4079,128 shs$387.07 million Get the Latest News and Ratings for ANRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alto Neuroscience and its competitors with MarketBeat's FREE daily newsletter. 05/01/2024$15.51$16.10+3.80%$16.53$14.91130,016 shs$432.77 million04/30/2024$15.56$15.51-0.32%$15.94$15.2371,418 shs$416.91 million04/29/2024$14.18$15.56+9.73%$16.29$14.4266,236 shs$418.32 million04/26/2024$14.13$14.14+0.07%$14.16$13.9622,746 shs$380.08 million04/25/2024$14.20$14.13-0.49%$14.44$13.7644,944 shs$379.81 million04/24/2024$13.88$14.20+2.31%$14.35$13.7436,767 shs$381.70 million04/23/2024$13.61$13.88+1.98%$14.30$13.7085,381 shs$373.09 million04/22/2024$12.96$13.61+5.02%$13.70$12.8879,989 shs$365.84 million04/19/2024$13.54$12.96-4.28%$13.81$12.78235,741 shs$348.37 million04/18/2024$13.48$13.54+0.45%$13.63$13.1379,670 shs$363.96 million04/17/2024$13.54$13.48-0.44%$13.80$13.24155,358 shs$362.34 million04/16/2024$14.09$13.54-3.90%$14.14$13.4280,719 shs$363.96 million04/15/2024$14.27$14.09-1.26%$14.54$13.5358,209 shs$378.80 million04/12/2024$14.11$14.27+1.13%$14.40$13.8961,354 shs$383.58 million04/11/2024$14.06$14.11+0.36%$14.30$13.86100,180 shs$379.33 million04/10/2024$14.73$14.06-4.55%$15.20$13.90117,997 shs$377.93 million04/09/2024$14.21$14.73+3.66%$14.86$14.1274,237 shs$395.94 million04/08/2024$14.52$14.21-2.13%$15.03$13.9588,715 shs$381.97 million04/05/2024$14.09$14.52+3.05%$14.80$13.9278,159 shs$390.30 million04/04/2024$14.18$14.09-0.63%$14.57$13.85141,284 shs$378.74 million04/03/2024$14.11$14.18+0.50%$14.43$14.05142,868 shs$381.16 million04/02/2024$14.56$14.11-3.09%$15.27$13.75170,528 shs$379.28 million04/01/2024$15.35$14.56-5.15%$15.35$14.18276,298 shs$391.43 million03/29/2024$15.39$15.35-0.26%$16.67$15.34208,815 shs$412.61 million03/28/2024$16.78$15.39-8.28%$16.83$15.39208,812 shs$413.68 million03/27/2024$17.90$16.78-6.26%$18.31$16.66162,716 shs$451.05 million03/26/2024$16.65$17.90+7.51%$18.35$16.95243,411 shs$481.15 million03/25/2024$15.97$16.65+4.26%$17.76$15.90261,112 shs$447.55 million03/22/2024$15.09$15.97+5.83%$16.35$14.84349,982 shs$408.35 million03/21/2024$15.03$15.09+0.40%$15.71$14.77270,904 shs$385.91 million03/20/2024$14.39$15.03+4.45%$15.67$13.97477,901 shs$384.32 million03/19/2024$14.16$14.39+1.62%$15.18$14.02448,933 shs$367.95 million03/18/2024$15.81$14.16-10.44%$15.86$13.60342,335 shs$362.07 million03/15/2024$14.90$15.81+6.11%$16.00$14.62804,117 shs$404.26 millionDems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE.03/14/2024$14.20$14.90+4.93%$15.33$13.85285,100 shs$380.99 million03/13/2024$14.54$14.20-2.34%$14.70$13.55263,754 shs$363.09 million03/12/2024$14.52$14.54+0.14%$15.04$13.93126,115 shs$371.79 million03/11/2024$13.76$14.52+5.52%$15.00$14.00137,369 shs$371.28 million03/08/2024$14.14$13.76-2.69%$15.05$13.52220,850 shs$351.84 million03/07/2024$14.81$14.14-4.52%$15.90$13.99143,889 shs$361.62 million03/06/2024$16.00$14.81-7.44%$17.06$14.75305,661 shs$378.69 million03/05/2024$15.71$16.00+1.85%$16.45$15.14266,132 shs$409.12 million03/04/2024$14.88$15.71+5.58%$16.88$15.00194,448 shs$401.71 million03/01/2024$15.29$14.88-2.68%$16.38$14.33207,353 shs$380.48 million02/29/2024$15.33$15.29-0.26%$15.67$14.60116,695 shs$390.97 million02/28/2024$14.43$15.33+6.24%$16.05$14.60223,272 shs$391.99 million02/27/2024$15.31$14.43-5.75%$16.44$13.72274,488 shs$368.98 million02/26/2024$13.72$15.31+11.59%$16.49$13.80325,776 shs$391.48 million02/23/2024$13.00$13.72+5.54%$14.04$13.00155,413 shs$350.82 million02/22/2024$13.47$13.00-3.49%$14.01$12.83211,125 shs$332.46 million02/21/2024$13.55$13.47-0.59%$14.28$12.93107,239 shs$344.43 million02/20/2024$15.86$13.55-14.56%$15.99$13.55309,236 shs$346.47 million02/19/2024$15.86$15.86$16.19$15.61216,500 shs$405.54 million02/16/2024$15.90$15.88-0.13%$16.04$15.66216,583 shs$406.05 million02/15/2024$15.00$15.90+6.00%$16.32$14.93384,852 shs$406.56 million02/14/2024$14.25$15.00+5.26%$15.88$14.01244,026 shs$383.55 million02/13/2024$13.93$14.25+2.30%$14.85$13.38198,776 shs$364.37 million02/12/2024$16.55$13.93-15.83%$17.40$13.75458,790 shs$356.19 million02/09/2024$18.98$16.55-12.80%$19.00$16.26171,139 shs$0.0002/08/2024$18.98$18.98$19.66$17.86218,362 shs$0.00 Related Companies: Esperion Therapeutics Stock Chart Amarin Stock Chart Heron Therapeutics Stock Chart Erasca Stock Chart Harrow Health Stock Chart Nkarta Stock Chart Nature's Sunshine Products Stock Chart ADC Therapeutics Stock Chart Rani Therapeutics Stock Chart Mereo BioPharma Group Stock Chart Receive ANRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alto Neuroscience and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:ANRO) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaObama’s Forever Term [exposed]Porter & CompanyThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders348 million Americans lives to END as we know it?The Oxford ClubUrgent Nvidia WarningAltimetryRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.